The Santa Barbara Zoo, in Santa Barbara, California, euthanized its 8-year-old female capybara Poppy on Friday after specialist veterinarians determined that a mass in her throat was inoperable, the zoo announced in a social media post confirmed by multiple local outlets. Noozhawk first reported the news, citing a zoo spokesperson.
Animal care staff noticed Poppy was breathing irregularly and initiated a diagnostic workup that included a CT scan and an endoscopic examination performed by a veterinary specialist. The mass was found to be extensive, severely obstructing her airway. “Knowing there was no treatment that could give Poppy a meaningful chance of recovery, we made the heartbreaking decision to humanely euthanize her rather than allow her to suffer,” said Dr. Julie Barnes, Vice President of Animal Care and Health at the Santa Barbara Zoo, in a statement carried by edhat.
Poppy’s background and age context
Poppy was born on 5 August 2018 at the Greater Vancouver Zoo and was hand-raised by caretakers from puppyhood. She had just turned 8 years old ten days before her death. Zoo officials described her as geriatric: capybaras typically live up to seven years in the wild, making Poppy roughly double the average wild lifespan at the time of her death. The Santa Barbara News-Press noted that the zoo nonetheless characterised her sudden decline as “no less painful a loss.”
Antonio’s concurrent cancer diagnosis
The zoo’s only remaining capybara, Antonio, is facing a separate and serious illness. Staff first observed that the 4-year-old male was experiencing nosebleeds and appeared unwell approximately two months before the announcement. Bone marrow biopsies and additional diagnostic testing confirmed a diagnosis of multiple myeloma, a blood cancer originating in plasma cells of the bone marrow.
Antonio has been off-habitat throughout his treatment and is now receiving chemotherapy in partnership with a veterinary oncology specialist. The zoo reported some improvement since corticosteroid treatment began and said staff are closely monitoring his response, comfort, and quality of life. His prognosis, the zoo stated, “remains guarded.”
The case carries significance beyond the zoo’s own walls. According to the zoo, this is the first known instance of multiple myeloma being successfully diagnosed in a living capybara at an Association of Zoos and Aquariums (AZA)-accredited institution, as edhat reported. Antonio was born on 26 July 2022 at the Montgomery Zoo in Alabama.
A difficult summer at the zoo
The two capybara cases are the latest in a run of losses at the Santa Barbara Zoo this summer. Earlier in the season, the zoo announced the deaths of three red pandas: two cubs born to a pair named Ruby and Raj, and subsequently their mother Ruby. The first cub was found dead in its nest box during a routine check; the second was transferred to an incubator for specialised care. The Santa Barbara News-Press described the capybara news as “the latest tragedy at the Santa Barbara Zoo in recent weeks.” Zoo escapes and animal losses are not uncommon across institutions worldwide; the Wikipedia list of zoo escapes documents dozens of notable incidents at zoos globally, illustrating the range of challenges animal care teams routinely face.
What remains unconfirmed
The zoo has not publicly disclosed the specific type of mass found in Poppy’s throat — whether it was a tumour, cyst, or other growth — nor has it released a cause. The timeline between the onset of irregular breathing and the decision to euthanize has not been given precisely. For Antonio, the zoo has not specified how many chemotherapy sessions have been administered, what drug protocol is being used, or when a clearer prognosis is expected.
The Grumpy Capy take
Two capybaras, two serious diagnoses, one summer: the Santa Barbara Zoo is dealing with an unusual concentration of bad luck in a single enclosure. Poppy’s case was resolved quickly and grimly once imaging confirmed the obstruction. Antonio’s is more open-ended, and the zoo is right to flag the scientific dimension — a confirmed multiple myeloma diagnosis in a living capybara at an AZA institution is genuinely uncommon, whatever the outcome.
The red panda losses earlier this summer add context without explaining anything. These are separate species, separate enclosures, separate pathologies. What they share is a zoo that has had to communicate a string of losses to its public in a short window, and appears to be doing so with reasonable clinical specificity rather than vague reassurances.
Antonio’s prognosis being “guarded” is the honest framing. Chemotherapy in a capybara is not a routine undertaking, and the zoo has been careful not to promise remission. Whether his case will ultimately add to the veterinary literature on multiple myeloma in rodents is a question that will take months, not weeks, to answer.
